推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

The true cost of pharmacological disease prevention

TLN Järvinen, H Sievänen, P Kannus, J Jokihaara… - BMJ, 2011 - bmj.com
Recently, van Staa and colleagues assessed the external validity of published cost effectiveness
studies of selective cyclo-oxygenase-2 (COX 2) inhibitors by comparing the data used in these
studies (typically from randomised trials) with observed clinical data.2 The trial data ...
Cited by 5 - Related articles - All 4 versions

Role of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective

M Elam, LC Lovato… - Current Opinion in Lipidology, 2011 - journals.lww.com
Purpose of review: To examine the results of the Action to Control Cardiovascular Risk in Diabetes
(ACCORD)-Lipid trial, particularly the subgroup analyses. It is important, when a study fails to
meet its overall primary endpoint, to ensure that interpretation of the results include ...
Cited by 2 - Related articles - All 4 versions

Neurodegenerative disease biomarkers: Guideposts for disease prevention through early diagnosis and intervention.

JQ Trojanowski… - Progress in neurobiology, 2011 - ncbi.nlm.nih.gov
1. Prog Neurobiol. 2011 Jul 23. [Epub ahead of print] Neurodegenerative disease
biomarkers: Guideposts for disease prevention through early diagnosis and
intervention. Trojanowski JQ, Hampel H. Department of Pathology ...

Potential National and State Medical Care Savings From Primary Disease Prevention

[HTML] from aphapublications.orgBA Ormond, BC Spillman… - … journal of public …, 2011 - ajph.aphapublications.org
Barbara A. Ormond, Brenda C. Spillman, and Timothy A. Waidmann are with the Health Policy
Center at The Urban Institute, Washington, DC. At the time of the study, Kyle J. Caswell was with
the Health Policy Center at The Urban Institute and American University, Washington, DC. ...
Cited by 3 - Related articles - All 8 versions

Prospects for a cardiovascular disease prevention polypill

KC Dabhadkar, A Kulshreshtha, MK Ali… - Annu. Rev. Public …, 2011 - papers.ssrn.com
Abstract: Cardiovascular diseases (CVD) account for one-third of annual global mortality. The
aggregated benefits of concurrently controlling common CVD risk factors, such as dyslipidemia
and hypertension, in people at overall risk for CVD is postulated to be more efficient than ...
Cited by 2 - Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451